The aim of this study was to assess and compare the Response Evaluation Criteria in Solid Tumors version (RECIST ) and the Choi criteria in evaluating the early response of advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) treated with sunitinib. |